Bexarotene is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Upsher-smith Laboratories, Inc.. The primary component is Bexarotene.
| Product ID | 0832-0285_eb936db9-0875-4fe3-adb4-df4de7e5193d |
| NDC | 0832-0285 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Bexarotene |
| Generic Name | Bexarotene |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-07-25 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA209886 |
| Labeler Name | Upsher-Smith Laboratories, Inc. |
| Substance Name | BEXAROTENE |
| Active Ingredient Strength | 75 mg/1 |
| Pharm Classes | Retinoid [EPC],Retinoids [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2018-07-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA209886 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-07-25 |
| Ingredient | Strength |
|---|---|
| BEXAROTENE | 75 mg/1 |
| SPL SET ID: | 7437a43f-172a-4f4e-8132-fe23b00224f9 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0054-0399 | Bexarotene | bexarotene |
| 0378-6955 | Bexarotene | Bexarotene |
| 0591-2832 | bexarotene | bexarotene |
| 0832-0285 | Bexarotene | Bexarotene |
| 42292-007 | Bexarotene | Bexarotene |
| 43975-315 | Bexarotene | Bexarotene |
| 68682-002 | bexarotene | bexarotene |
| 68682-003 | bexarotene | bexarotene |
| 69238-1250 | Bexarotene | Bexarotene |
| 69238-2088 | Bexarotene | Bexarotene |
| 0187-5525 | Targretin | bexarotene |
| 0187-5526 | Targretin | bexarotene |